Filter Model virus3 LRV1,2 Ref.
Viresolve Pro xMuLV ≥3.72 (Gefroh, Dehghani et al. 2014)
≥4.8 (Miesegaes, Lute et al. 2010)
≥4.43 - ≥5.89 (Stuckey, Strauss et al. 2014)
Reo-3 ≥5.21 (Gefroh, Dehghani et al. 2014)
≥4.78 - ≥6.63 (Stuckey, Strauss et al. 2014)
PRV ≥3.56 (Gefroh, Dehghani et al. 2014)
≥4.10 - ≥5.52 (Stuckey, Strauss et al. 2014)
Viresolve NFP xMuLV ≥3.99 (Gefroh, Dehghani et al. 2014)
Reo-3 ≥4.62
PRV ≥4.23
Virosart CPV Reo-3 ≥4.96 - ≥6.87 (Stuckey, Strauss et al. 2014)
MuLV ≥4.30 - ≥5.39 (Stuckey, Strauss et al. 2014)
>6.9 (Miesegaes, Lute et al. 2010)
PRV ≥2.52 - ≥2.72 (Stuckey, Strauss et al. 2014)
Planova 20N xMuLV ≥4.67 – ≥6.93 (single spike) (Stuckey, Strauss et al. 2014)
≥4.65 – ≥7.45 (co-spike with PPV)
Approx. ≥3.9 – ≥7.0 (Gefroh, Dehghani et al. 2014)
>5.2 (Miesegaes, Lute et al. 2010)
Pall DV20 xMuLV >5.3 (Miesegaes, Lute et al. 2010)
Pall DV50 xMuLV >5.6 (Miesegaes, Lute et al. 2010)
Various nominal pore size 15-20 nm filters (Planova 20N, Planova BioEX, Viresolve Pro, Viresolve NFP, Ultipor DV20, Pegasus SV4, Pegasus Prime, Virosart CPV, Virosart HF, Virosart HC) Approx. 25-40 nm (such as HAV, BEV, EMCV, PEV, HPV-1, TMEV; FCV, SV40) Approx. ≥ 0.8 - ≥ 7.5 (some cases viruses were detected in the filtrate. For those runs, LRVs were 2.0 – 6.9) (Roth, Dichtelmüller et al. 2020)
Approx. 50-70 nm (such as BVDV, WNV; SINV, SFV) Approx. ≥ 3.0 - ≥ 8.5
Approx. 70-120 nm (such as Reo3; HIV; VSV) Approx. ≥ 3.6 - ≥ 8.0
>120 nm (such as PRV, HSV-1, IBRV) Approx. ≥ 4.0 - ≥ 8.5
Various small virus retentive filters (not specified) MuLV >99% of the cases, no detectable virus in the filtrate. Majority of the cases, LRV >4. (Stuckey, Strauss et al. 2014)
Reo-3 >99% of the cases, no detectable virus in the filtrate. Majority of the cases, LRV >4.
PRV >98% of the cases, no detectable virus in the filtrate. Majority of the cases, LRV >4.